Racial-ethnic disparities in management and outcomes among children with type 1 diabetes

Steven M Willi1, Kellee M Miller2, Linda A DiMeglio3

  • 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;

Pediatrics
|February 18, 2015
PubMed

Insights

Racial disparities persist in pediatric type 1 diabetes care, with Black children experiencing worse outcomes and less insulin pump use than White or Hispanic children, even after accounting for socioeconomic status.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Research
  • Health Disparities

Background:

  • Previous research indicates racial/ethnic disparities in diabetes treatments and outcomes.
  • It remains debated whether these disparities stem from socioeconomic status (SES) or other factors.

Purpose of the Study:

  • To examine racial/ethnic disparities in therapeutic modalities and diabetes outcomes.
  • Focus on pediatric participants in the T1D Exchange Clinic Registry.

Main Methods:

  • Analyzed data from 10,704 pediatric participants (<18 years) with type 1 diabetes.
  • Compared diabetes management and outcomes among non-Hispanic white, non-Hispanic black, and Hispanic participants.
  • Adjusted for gender, age, diabetes duration, and socioeconomic status.

Main Results:

  • Insulin pump use was significantly lower in Black (26%) and Hispanic (39%) children compared to White children (61%), even after SES adjustment.
  • Black children had higher mean hemoglobin A1c (9.6%) and experienced more diabetic ketoacidosis and severe hypoglycemia than White (8.4%) or Hispanic (8.7%) children.
  • No significant differences in outcomes were found between White and Hispanic participants after SES adjustment.

Conclusions:

  • Significant disparities in insulin treatment and outcomes persist between Black children and White/Hispanic children, independent of SES.
  • Further research is needed to identify barriers to insulin pump use and optimal glycemic control beyond SES in all ethnic groups.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
96.0K